Type 2 diabetes is a significant CVD risk factor. However, the independent contribution of hyperglycemia per se to CVD risk remains uncertain.
The hyperglycemic state of diabetes is only one of the dysmetabolic components observed in patients, who are often abdominally obese.
The cluster of atherogenic metabolic abnormalities now often referred to as the metabolic syndrome is known to increase the risk of type 2 diabetes and CVD.
Intervention trials have shown that reducing body weight in overweight and obese subjects at high risk of developing diabetes could substantially reduce their risk of developing diabetes.
Age is also an important factor to consider when evaluating the CVD risk of diabetic patients.
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62